Juergen Behr

Author PubWeight™ 67.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011 22.39
2 High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 2005 7.20
3 An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med 2015 6.03
4 Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation 2013 3.90
5 BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011 3.23
6 The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med 2009 2.18
7 Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 2002 1.72
8 Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. Eur Respir J 2013 1.68
9 Hot of the breath: mortality as a primary end-point in IPF treatment trials: the best is the enemy of the good. Thorax 2012 1.65
10 Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax 2012 1.61
11 Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med 2013 1.51
12 Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol 2012 1.48
13 The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2009 1.46
14 Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006 1.26
15 Determining collateral ventilation during bronchoscopy: unanswered questions. Thorax 2013 1.13
16 Successful angioplasty and stent treatment of pulmonary vein stenosis after single-lung transplantation. J Heart Lung Transplant 2009 0.99
17 Long-term therapy with inhaled iloprost in patients with pulmonary hypertension. Respir Med 2010 0.98
18 Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J 2012 0.96
19 Pulmonary arterial hypertension: diagnosis with fast perfusion MR imaging and high-spatial-resolution MR angiography--preliminary experience. Radiology 2005 0.95
20 Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis. Transpl Int 2010 0.93
21 Is sirolimus a therapeutic option for patients with progressive pulmonary lymphangioleiomyomatosis? Respir Res 2011 0.89
22 Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients. J Heart Lung Transplant 2009 0.86
23 Mortality, a bar too high for idiopathic pulmonary fibrosis clinical trials! Am J Respir Crit Care Med 2013 0.86
24 Anti-inflammatory effects of antibacterials on human Bronchial epithelial cells. Respir Res 2009 0.85
25 Inflammatory responses of airway smooth muscle cells and effects of endothelin receptor antagonism. Am J Respir Cell Mol Biol 2013 0.80
26 Haemodynamic changes in pulmonary hypertension in patients with interstitial lung disease treated with PDE-5 inhibitors. Respirology 2014 0.79
27 Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis. Respiration 2015 0.77
28 Pulmonary hypertension: role of combination therapy. Curr Vasc Pharmacol 2011 0.76
29 Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability. Ther Drug Monit 2017 0.75
30 Riociguat for the treatment of pulmonary hypertension. Expert Opin Pharmacother 2014 0.75
31 High prevalence of pneumonia in children of a smelter town. Int J Occup Environ Health 2007 0.75